BBNX vs HUBB · rev $100.3M vs P/E 28, rev $5.84B
Beta Bionics, Inc. Common Stock (BBNX) versus Hubbell Inc (HUBB) — a side-by-side from cached financials, not a winner call.
Beta Bionics, Inc. Common Stock (BBNX) is a medical devices company listed on NASDAQ.
Hubbell Inc (HUBB) is a electrical equipment & parts company listed on US.
Latest reported BBNX revenue for 2025-12-31 was $100.3M. Net income was -$73.2M. Revenue was up 53.9% from 2024-12-31 to 2025-12-31. BBNX currently screens at market cap $640.8M.
Latest reported HUBB revenue for 2025-12-31 was $5.84B. Net income was $887.1M. Revenue was up 3.8% from 2024-12-31 to 2025-12-31. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
BBNX currently screens at market cap $640.8M. HUBB currently screens at market cap $22.14B and trailing P/E 28.0.
Not investment advice. Open the BBNX and HUBB stock pages for the full models.
Not investment advice.